BIIB vs SATA
Biogen Inc (BIIB) versus Strive, Inc. Variable Rate Series A Perpetual Preferred Stock (SATA) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Strive, Inc. Variable Rate Series A Perpetual Preferred Stock (SATA) is a asset management company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
SATA does not have a complete income-statement cache yet.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. SATA currently screens at market cap $0.
Not investment advice. Open the BIIB and SATA stock pages for the full models.
Not investment advice.